Amarin Corporation PLC
AMRN15.380USD
+0.220+1.45%
收盘 08/04, 16:00（美东）报价延迟15分钟
319.44M总市值
亏损市盈率 TTM
关于 Amarin Corporation PLC 公司
Amarin Corporation PLC 是一家制药公司。该公司专注于改善心血管 (CV) 健康并降低 CV 风险的疗法的商业化和开发。该公司通过 VASCEPA 的开发和商业化开展业务。其主要产品 Vascepa（二十碳五烯酸乙酯）胶囊可作为饮食辅助剂，降低重度高甘油三酯血症成年患者的甘油三酯水平。Vascepa 的这一适应症称为 MARINE 适应症，主要基于 MARINE 对这一获批患者群体进行的 Vascepa 研究结果。该公司主要向批发商以及选定的区域批发商和专业药房供应商（统称为其分销商）销售 Vascepa，而后者又将 Vascepa 转售给零售药房，再转售给患者和医疗保健提供商。
公司简介
公司代码AMRN
公司名称Amarin Corporation PLC
上市日期Apr 01, 1993
CEOMr. Aaron D. Berg
员工数量275
证券类型Depository Receipt
年结日Apr 01
公司地址WeWork One Central Plaza Dame Street
城市DUBLIN
上市交易所NASDAQ Capital Market Consolidated
国家Ireland
邮编D02 K7K5
电话35316699020
网址https://amarincorp.com/
公司代码AMRN
上市日期Apr 01, 1993
CEOMr. Aaron D. Berg
公司高管
名称
名称/职务
职务
持股
持股变动
Ms. Diane E. Sullivan
Ms. Diane E. Sullivan
Non-Executive Independent Director
Non-Executive Independent Director
401.00
--
Mr. Oliver O'Connor
Mr. Oliver O'Connor
Non-Executive Independent Director
Non-Executive Independent Director
401.00
--
Dr. Paul Cohen, M.D.
Dr. Paul Cohen, M.D.
Non-Executive Independent Director
Non-Executive Independent Director
401.00
--
Ms. Patrice Bonfiglio
Ms. Patrice Bonfiglio
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Louis Sterling, III
Mr. Louis Sterling, III
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Peter Fishman
Mr. Peter Fishman
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Stephen B. (Steven) Ketchum, Ph.D.
Dr. Stephen B. (Steven) Ketchum, Ph.D.
President - Research and Development, Executive Vice President, Chief Scientific Officer
President - Research and Development, Executive Vice President, Chief Scientific Officer
--
--
Mr. Aaron D. Berg
Mr. Aaron D. Berg
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Keith L. Horn
Mr. Keith L. Horn
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Odysseas D. Kostas, M.D.
Dr. Odysseas D. Kostas, M.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Ms. Diane E. Sullivan
Ms. Diane E. Sullivan
Non-Executive Independent Director
Non-Executive Independent Director
401.00
--
Mr. Oliver O'Connor
Mr. Oliver O'Connor
Non-Executive Independent Director
Non-Executive Independent Director
401.00
--
Dr. Paul Cohen, M.D.
Dr. Paul Cohen, M.D.
Non-Executive Independent Director
Non-Executive Independent Director
401.00
--
Ms. Patrice Bonfiglio
Ms. Patrice Bonfiglio
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Louis Sterling, III
Mr. Louis Sterling, III
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Peter Fishman
Mr. Peter Fishman
Chief Financial Officer
Chief Financial Officer
--
--
收入明细
暂无数据
暂无数据
业务
地区
暂无数据
股东统计
更新时间: 7月23日 周三
更新时间: 7月23日 周三
持股股东
股东类型
持股股东
持股股东
占比
Sarissa Capital Management, L.P.
6.01%
Kynam Capital Management LP
3.00%
Acadian Asset Management LLC
0.92%
Eversept Partners, LP
0.82%
Two Sigma Investments, LP
0.79%
Other
88.47%
持股股东
持股股东
占比
Sarissa Capital Management, L.P.
6.01%
Kynam Capital Management LP
3.00%
Acadian Asset Management LLC
0.92%
Eversept Partners, LP
0.82%
Two Sigma Investments, LP
0.79%
Other
88.47%
股东类型
持股股东
占比
Hedge Fund
11.52%
Investment Advisor
3.36%
Investment Advisor/Hedge Fund
1.67%
Research Firm
0.96%
Individual Investor
0.95%
Pension Fund
0.14%
Family Office
0.10%
Bank and Trust
0.01%
Venture Capital
0.01%
Other
81.27%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
335
3.85M
18.62%
-1.48M
2025Q1
349
5.67M
20.22%
+144.25K
2024Q4
362
81.89M
19.91%
-21.31M
2024Q3
365
76.69M
18.66%
-50.88M
2024Q2
389
87.45M
21.29%
-59.57M
2024Q1
405
98.68M
24.03%
-57.40M
2023Q4
423
103.82M
25.42%
-56.37M
2023Q3
447
95.61M
23.44%
-78.96M
2023Q2
464
107.90M
26.46%
-89.05M
2023Q1
492
118.85M
29.19%
-104.01M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Sarissa Capital Management, L.P.
1.24M
6%
--
--
Mar 31, 2025
Kynam Capital Management LP
620.73K
3%
--
--
Mar 31, 2025
Acadian Asset Management LLC
189.58K
0.92%
+100.29K
+112.31%
Mar 31, 2025
Eversept Partners, LP
169.96K
0.82%
+94.13K
+124.13%
Mar 31, 2025
Two Sigma Investments, LP
162.85K
0.79%
-33.32K
-16.99%
Mar 31, 2025
WaterFront Wealth, Inc.
125.73K
0.61%
+1.64K
+1.32%
Mar 31, 2025
SCP Investment, LP
125.00K
0.6%
--
--
Mar 31, 2025
Morgan Stanley & Co. LLC
116.05K
0.56%
-87.42K
-42.96%
Mar 31, 2025
Longitude (Cayman) Ltd
81.00K
0.39%
-37.50K
-31.65%
Dec 31, 2024
Berg (Aaron D.)
80.71K
0.39%
+36.64K
+83.12%
Jun 26, 2025
查看更多
持股ETF
更新时间: 8月2日 周六
更新时间: 8月2日 周六
机构名称
占比
ProShares Ultra Nasdaq Biotechnology
0.04%
Invesco Nasdaq Biotechnology ETF
0.04%
SPDR S&P International Small Cap ETF
0.01%
SPDR Portfolio Developed World ex-US ETF
0%
Global X Aging Population ETF
0%
ActivePassive International Equity ETF
0%
Invesco NASDAQ Future Gen 200 ETF
0%
AltShares Event-Driven ETF
0%
ProShares Ultra Nasdaq Biotechnology
占比0.04%
Invesco Nasdaq Biotechnology ETF
占比0.04%
SPDR S&P International Small Cap ETF
占比0.01%
SPDR Portfolio Developed World ex-US ETF
占比0%
Global X Aging Population ETF
占比0%
ActivePassive International Equity ETF
占比0%
Invesco NASDAQ Future Gen 200 ETF
占比0%
AltShares Event-Driven ETF
占比0%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
Mar 12, 2025
Merger
20<1
公告日期
类型
比率
Mar 12, 2025
Merger
20<1
